Calton & Associates’s Omeros OMER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,694
Closed -$33.2K 275
2022
Q4
$33.2K Sell
14,694
-47
-0.3% -$130 0.01% 279
2022
Q3
$46K Sell
14,741
-354
-2% -$1.64K 0.03% 209
2022
Q2
$41K Sell
15,095
-794
-5% -$2.69K 0.02% 233
2022
Q1
$95K Buy
15,889
+1,786
+13% +$11.1K 0.03% 341
2021
Q4
$90K Sell
14,103
-267
-2% -$1.94K 0.02% 359
2021
Q3
$198K Sell
14,370
-83
-0.6% -$1.24K 0.04% 378
2021
Q2
$214K Sell
14,453
-344
-2% -$5.77K 0.04% 372
2021
Q1
$263K Sell
14,797
-9
-0.1% -$175 0.05% 307
2020
Q4
$212K Buy
14,806
+1,557
+12% +$19K 0.04% 355
2020
Q3
$134K Sell
13,249
-1,309
-9% -$16.9K 0.03% 327
2020
Q2
$214K Sell
14,558
-52
-0.4% -$776 0.05% 291
2020
Q1
$195K Buy
14,610
+3,403
+30% +$45.3K 0.05% 273
2019
Q4
$158K Buy
11,207
+283
+3% +$4.14K 0.03% 345
2019
Q3
$178K Buy
+10,924
New +$187K 0.04% 326

Other funds holding OMER

Calton & Associates's OMER Position: Q1 2023 in Review

Calton & Associates sold out of Omeros (OMER) in Q1 2023, closing a stake of 14,694 shares — an estimated $33.2K sold.

Calton & Associates first reported a position in OMER in Q3 2019 and held it in 14 quarters. The position peaked at $263K in Q1 2021. 90 funds tracked by Wall St. Rank hold OMER as of Q1 2023.

  • Calton & Associates reported no remaining Omeros position as of Q1 2023 after selling out during the quarter.
  • Calton & Associates sold 14,694 Omeros shares in Q1 2023, an estimated $33.2K.
  • Calton & Associates first reported a position in Omeros in Q3 2019 and held it in 14 quarters.
  • Calton & Associates's Omeros position peaked at $263K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Omeros as of Q1 2023.

Based on Calton & Associates's 13F filing for Q1 2023, filed 19 Apr 2023.